News on technologies and applications for point-of-care testing.
The test, developed by the firms in six weeks, is part of a viral respiratory panel and runs on Bosch's point-of-care Vivalytic system.
Credo Diagnostics recently received the CE mark for the coronavirus test, which can provide results in 20 minutes.
The assay, which resembles a pregnancy test, is authorized for use in laboratories certified under CLIA to perform as moderate- and highly-complexity tests.
The firm had been in stealth mode, but hopes to now attract partners to further commercialize its system for decentralized testing.
Bringing testing closer to patients could be helpful, provided enough tests and instruments can be manufactured and distributed.
